FFL
LGND icon

Future Fund LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Future Fund LLC’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.65M Buy
14,704
+864
+6% +$204K 1.33% 22
2026
Q1 		$2.76M Buy
13,840
+4,560
+49% +$902K 0.97% 41
2025
Q4 		$1.75M Buy
+9,280
New +$1.78M 0.56% 66

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Future Fund LLC's LGND Position: Q2 2026 in Review

Future Fund LLC increased its Ligand Pharmaceuticals (LGND) stake by 6.2% in Q2 2026, buying an estimated $204K and bringing the position to 14,704 shares worth $4.65M. The position accounts for 1.33% of the portfolio, ranked #22.

Future Fund LLC first reported a position in LGND in Q4 2025 and has held it in 3 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Future Fund LLC held 14,704 shares of Ligand Pharmaceuticals worth $4.65M as of Q2 2026.
  • Future Fund LLC bought 864 Ligand Pharmaceuticals shares in Q2 2026, an estimated $204K.
  • Ligand Pharmaceuticals made up 1.33% of Future Fund LLC's portfolio in Q2 2026, its #22 holding.
  • Future Fund LLC first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Future Fund LLC's 13F filing for Q2 2026, filed 12 Aug 2026.